1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33:160-172.

2. Nisenbaum R, Reyes M, Mawle AC, Reeves WC. Factor analysis of unexplained severe fatigue and inter-related symptoms. Overlap with the criteria for chronic fatigue syndrome. Am J Epidemiol 148, 72-77. 1998.

3. Clauw DJ, Chrousos GP. Chronic Pain and Fatigue Syndromes: Overlapping Clinical and Neuroendocrine Features and Potential Pathogenic Mechanisms. Neuroimmunomodulation 1997; 4:134-153.

4. Hudson JI, Goldenberg DL, Pope HG, Jr., Keck PE, Jr., Schlesinger L. Co-morbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 1992; 92:363-367.

5. Buskila D, Neumann L, Vaisberg G, Alkalay D, Wolfe F. Increased rates of fibromyalgia following cervical spine injury. A controlled study of 161 cases of traumatic injury. Arthritis Rheum 1997; 40(3):446-452.

6 . Fukuda K., Nisenbaum R, Stewart G., Thompson W.T., Robin L., Washko R.M. et al. Chronic mutlisymptom illness affecting air force veterans of the gulf war. JAMA 280[11], 981-988. 1999.

7 . Unwin C, Blatchley N., Coker W., Ferry S., Hotopf M., Hull L. et al. Health of UK servicemen who served in the Persian Gulf War. Lancet 353, 169-178.1999.

8 . Clauw D.J. The "Gulf War Syndrome": implications for rheumatologists. J Clin Rheum 4[4], 173-174. 1998.

9 . Yunus MB. Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation [editorial]. J Rheumatol 1992; 19:846-850.

10 Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994; 37:1593-1601.

11 Demitrack MA, Dale JK, Straus SE, Laue L, Listwak SJ, Kruesi MJ et al. Evidence for impaired activation of the hypothalamic-pituitary- adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991; 73:1224-1234.

12 Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992; 267:1244-1252.

13 Romero LM, Plotsky PM, Sapolsky RM. Patterns of adrenocorticotropin secretagogue release with hypoglycemia, novelty, and restraint after colchicine blockade of axonal transport. Endocrinology 1993; 132:199-204.

14 Viau V, Sharma S, Plotsky PM, Meaney MJ. Increased plasma ACTH responses to stress in nonhandled compared with handled rats require basal levels of corticosterone and are associated with increased levels of ACTH secretagogues in the median eminence. J Neurosci 1993; 13:1097-1105.

15 Sapolsky RM. Why stress is bad for your brain. Science 1996; 273:749-750.

16 Lautenbacher S, Rollman GB, McCain GA. Multi-method assessment of experimental and clinical pain in patients with fibromyalgia. Pain 1994; 59(1):45-53.

17 Arroyo JF, Cohen ML. Abnormal responses to electrocutaneous stimulation in fibromyalgia. J Rheumatol 1993; 20(11):1925-1931.

18 Crofford LJ. Neuroendocrine abnormalities in fibromyalgia and related disorders. Am J Med Sci 315[6], 359-366. 1998.

19 Sternberg EM. Hyperimmune fatigue syndromes: Diseases of the stress response? J Rheumatol 1993; 20:3:418-421.

20 Bearn J, Allain T, Coskeran P, Munro N, Butler J, McGregor A et al. Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome. Biol Psychiatry 1995; 37:245-252.

21 Griep EN, Boersma JW, de Kloet ER. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 1993; 20:469-474.

22 Crofford LJ, Pillemer SR, Kalogeras KT, Cash JM, Michelson D, Kling MA et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994; 37(11):1583-1592.

23 Kalik K. Projections of the cerebellar and dorsal column nuclei upon the thalamus of the rhesus mokey. J Comp Neurol 1981; 195:25-50.

24 Kosek E, Ekholm J, Hansson P. Sensory dysfunction in fibromyalgia patients with implications for pathogenic mechanisms. Pain 1996; 68(2-3):375-383.

25 Strick PL. Anatomical analysis of ventrolateral thalamic input to primate motor cortex. J Neurophysiol 1976; 39:1020-1031.

26 Ilinsky IA, Kultas-Ilinsky K. Saggital cytoarchitectonic maps of Macaca Mulatta thalamus with a revised nomenclature of the motor-related nuclei validated by observation on their connectivity. J Comp Neurol 1987; 262:331-364.

27 van Denderen JC, Boersma JW, Zeinstra P, Hollander AP, van Neerbos BR. Physiological effects of exhaustive physical exercise in primary fibromyalgia syndrome (PFS): is PFS a disorder of neuroendocrine reactivity? Scand J Rheumatol 1992; 21:35-37.

28 Torpy DJ, Papanicolaou DA, Pillemer SR, Wilder RL, Chrousos GP. Hypersecretory response of adrenocorticotropin to interleukin-6 in patients with fibromyalgia. Biomedicine 1997.

29 Elam M, Johansson G, Wallin BG. Do patients with primary fibromyalgia have an altered muscle sympathetic nerve activity? Pain 1992; 48:371-375.

30 Boudoulas H, Wooley CF. Mitral valve prolapse syndrome: evidence of autonomic dysfunction. J Cardiol Suppl 1987; 14:3-12.

31 Hadler NM. Backache and work incapacity in Japan. J Occup Med 1994; 36:1110-1114.

32 Qiao ZG, Vaer:y H, M:rkrid L. Electrodermal and microcirculatory activity in patients with fibromyalgia during baseline, acoustic stimulation and cold pressor tests. J Rheumatol 1991; 18:1383-1389.

33 Yehuda R, Teicher MH, Levengood RA, Trestman RL, Siever LJ. Circadian regulation of basal cortisol levels in posttraumatic stress disorder. Ann N Y Acad Sci 1994; 746:378-380.

34 Mason JW, Giller EL, Kosten TR, Ostroff RB, Podd L. Urinary free-cortisol levels in posttraumatic stress disorder patients. J Nervous Mental Dis 174, 145-149.1986.

35 Vanderpool J, Rosenthal N, Chrousos GP, Wher T, Gold PW. Evidence for hypothalamic CRH deficiency in patients with seasonal affective disorder. J Clin Endocrinol Metab 72, 1382-1387. 1991.

36 Gold PW, Goodwin F, Chrousos GP. Clinical and biochemical manifestations of depression: relationship to the neurobiologyof stress (part 1). N Eng J Med 319, 348-353. 1988.
Ref Type: Journal (Full)

37 Asanuma C, Thach WT, Jones EG. Distribution of cerebellar terminations and their relation to other afferent terminationsin the thalamic ventral lateral region of the monkey. Brain Res Rev 1983; 5:237-265.

38 Anisman H, Zacharko R. Depression as a consequence of inadequate neurochemical adaptation in response to stressors. Br J Psychiatry Suppl 1992; 15:36-43.

39 Bennett RM, Clark SR, Campbell SM, Burckhardt CS. Low levels of somatomedin C in patients with the fibromyalgia syndrome. A possible link between sleep and muscle pain. Arthritis Rheum 1992; 35:1113-1116.

40 Russell IJ, Vipraio GA, Michalek JE, Lopez YG. Insulin-like growth factor in fibromyalgia, rheumatoid arthritis, osteoarthritis, and healthy normal controls: roles of diagnosis, age, sex, and ethnic origin. Arthritis Rheum 35(9S),B263.1992.

41 Bennett RM, Cook DM, Clark SR, Campbell SM, Burckhardt CS. Low somatomedin-C in fibromyalgia patients: an analysis of clinical specificity and pituitary/hepatic responses. Arthritis Rheum 1993; 36(9S):62.

42 Thach WT, Jones EG. The cerebellar denatothalamic connection: Terminal field, lamellae, rods , and somatotopy. Brain Res 1979; 169:168-172.

43 Neeck G, Riedel W. Thyroid function in patients with fibromyalgia syndrome. J Rheumatol 1992; 19:1120-1122.

44 Yunus MB, Ahles TA, Aldag JC, Masi AT. Relationship of clinical features with psychological status in primary fibromyalgia. Arthritis Rheum 1991; 34:15-21.

45 Hadler NM. Fibromyalgia, chronic fatigue, and other iatrogenic diagnostic algorithms. Do some labels escalate illness in vulnerable patients. Postgrad.Med. 102[2], 161-177. 1997.

46 Boissevain MD, McCain GA. Toward an integrated understanding of fibromyalgia syndrome. II. Psychological and phenomenological aspects. Pain 1991; 45:239-248.

47 Hudson JI, Hudson MS, Pliner LF, Goldenberg DL, Pope HGJr. Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry 1985; 142 (4):441-446.

48 Aaron LA, Bradley LA, Alarcon GS, Alexander RW, Triana-Alexander M, Martin MY et al. Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum 1996; 39:436-445.

49 N.I.H.Technology Panel. Integration of behavioral and relaxation approaches into the treatment of chronic pain and insomnia. Journal of the American Medical Association 1996;(276):313-318.

50 Granges G, Littlejohn G. Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum 1993; 36:642-646.

51 Clauw DJ. Fibromyalgia: more than just a musculoskeletal disease. Am Fam Phys 1995; 52(3):843-851.

52 Bates DW, Buchwald D, Lee J, Kith P, Doolittle T, Rutherford C et al. Clinical laboratory test findings in patients with chronic fatigue syndrome. Arch Intern Med 1995; 155:97-103.

53 Pincus T. A pragmatic approach to cost-effective use of laboratory tests and imaging procedures in patients with musculoskeletal symptoms. Prim Care 1993; 20(4):795-814.

54 Carette S, Bell MJ, Reynolds WJ, Haraoui B, McCain GA, Bykerk VP et al. Comparison of amitriptyline, clyclobenzaprine, and placebo in the treatment of fibromyalgia. Arthritis and Rheumatism 1994; 37(1):32-40.

55 Godfrey RG. A guide to the understanding and use of tricyclic antidepressants in the overall management of fibromyalgia and other chronic pain syndromes. Arch Intern Med 1996; 156:1047-1052.

56 Minor MA, Hewett JE, Webel RR, Anderson SK, Kay DR. Efficacy of physical conditioning exercise in patients with rheumatoidal arthritis and osteoarthritis. Arthritis & Rheumatism 1989; 32:1396-1405.